Clinical Trials List
Protocol NumberD6960C00005
Not yet recruiting
2026-06-01 - 2028-12-31
Phase II
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- Yu-Tien Tzeng Division of Thoracic Medicine
- Kuan-Jen Bai Division of Thoracic Medicine
- Jer-Hwa Chang Division of Thoracic Medicine
- Shian-Jiun Lin Division of Thoracic Medicine
- Chih-Hsin Lee Division of Thoracic Medicine
- 石智元 Division of Thoracic Medicine
- Han-Lin Hsu Division of Thoracic Medicine
- 楊善堯 Division of Thoracic Medicine
Co-Principal Investigator
- WEI-WEN LIN Division of Cardiovascular Diseases
- 蕭亦均 Division of Thoracic Medicine
- 黃丞正 Division of Thoracic Medicine
- 王振宇 Division of Thoracic Medicine
- 陳昱瑋 Division of Cardiovascular Diseases
Co-Principal Investigator
- 鄭孟軒 Division of Thoracic Medicine
- 鄭至宏 Division of Thoracic Medicine
- jong rung Tsai Division of Thoracic Medicine
- Hung-Ling Huang Division of Thoracic Medicine
- Wei-An Chang Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- Ming-Ju Tsai Division of Thoracic Medicine
- 李岱晃 Division of Thoracic Medicine
Co-Principal Investigator
- 羅君禹 Division of Thoracic Medicine
- 張博瑞 Division of Thoracic Medicine
- 李忠恕 Division of Infectious Disease
- Shu-Min Lin Division of Infectious Disease
- 張美元 Division of Thoracic Medicine
- 胡漢忠 Division of Infectious Disease
- 黃建達 Division of Thoracic Medicine
- 謝孟亨 Division of Infectious Disease
- 林倡葦 Division of Infectious Disease
Co-Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
360 participants